These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38634880)
1. Dual-energy CT quantitative parameters to evaluate occult peritoneal metastasis in advanced gastric cancer preoperatively. Feng QX; Zhu ZN; Li Q; Liu XS Abdom Radiol (NY); 2024 Oct; 49(10):3309-3318. PubMed ID: 38634880 [TBL] [Abstract][Full Text] [Related]
2. Utility of Combined Use of Imaging Features From Abdominopelvic CT and CA 125 to Identify Presence of CT Occult Peritoneal Metastases in Advanced Gastric Cancer. Zhu ZN; Feng QX; Li Q; Xu WY; Liu XS J Comput Assist Tomogr; 2024 Sep-Oct 01; 48(5):734-742. PubMed ID: 38595104 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Quantitative Dual-Energy Computed Tomography Parameters for Differentiation of Parotid Gland Tumors. Wang Y; Hu H; Ban X; Jiang Y; Su Y; Yang L; Shi G; Yang L; Han R; Duan X Acad Radiol; 2024 May; 31(5):2027-2038. PubMed ID: 37730491 [TBL] [Abstract][Full Text] [Related]
4. Quantitative parameter analysis of pretreatment dual-energy computed tomography in nasopharyngeal carcinoma cervical lymph node characteristics and prediction of radiotherapy sensitivity. Li Z; Li C; Li L; Yang D; Wang S; Song J; Jiang M; Kang M Radiat Oncol; 2024 Jun; 19(1):81. PubMed ID: 38918834 [TBL] [Abstract][Full Text] [Related]
5. Combination of clinical and spectral-CT iodine concentration for predicting liver metastasis in gastric cancer: a preliminary study. She Y; Liu X; Liu H; Yang H; Zhang W; Han Y; Zhou J Abdom Radiol (NY); 2024 Oct; 49(10):3438-3449. PubMed ID: 38744700 [TBL] [Abstract][Full Text] [Related]
6. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer. Liu S; He J; Liu S; Ji C; Guan W; Chen L; Guan Y; Yang X; Zhou Z Eur Radiol; 2020 Jan; 30(1):239-246. PubMed ID: 31385045 [TBL] [Abstract][Full Text] [Related]
7. Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer. Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J Cancer Imaging; 2021 Jan; 21(1):4. PubMed ID: 33413654 [TBL] [Abstract][Full Text] [Related]
8. Assessing muscle invasion in bladder cancer via virtual biopsy: a study on quantitative parameters and classical radiomics features from dual-energy CT imaging. Hu M; Wei W; Zhang J; Wang S; Tong X; Fan Y; Cheng Q; Liu Y; Li J; Liu L BMC Med Imaging; 2024 Sep; 24(1):245. PubMed ID: 39285354 [TBL] [Abstract][Full Text] [Related]
9. Preoperative Prediction of Cervical Nodal Metastasis in Papillary Thyroid Carcinoma: Value of Quantitative Dual-Energy CT Parameters and Qualitative Morphologic Features. Wu YY; Wei C; Wang CB; Li NY; Zhang P; Dong JN AJR Am J Roentgenol; 2021 May; 216(5):1335-1343. PubMed ID: 33760651 [No Abstract] [Full Text] [Related]
10. Gastric cancer: development and validation of a CT-based model to predict peritoneal metastasis. Kim M; Jeong WK; Lim S; Sohn TS; Bae JM; Sohn IS Acta Radiol; 2020 Jun; 61(6):732-742. PubMed ID: 31653185 [TBL] [Abstract][Full Text] [Related]
11. Prediction of occult peritoneal metastases or positive cytology using CT in gastric cancer. Liu P; Ding P; Wu H; Wu J; Yang P; Tian Y; Guo H; Zhao Q Eur Radiol; 2023 Dec; 33(12):9275-9285. PubMed ID: 37414883 [TBL] [Abstract][Full Text] [Related]
12. Effect of Hashimoto's thyroiditis on the dual-energy CT quantitative parameters and performance in diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer. Geng D; Zhou Y; Shang T; Su GY; Lin SS; Si Y; Wu FY; Xu XQ Cancer Imaging; 2024 Jan; 24(1):10. PubMed ID: 38238870 [TBL] [Abstract][Full Text] [Related]
13. Differentiating pulmonary metastasis from benign lung nodules in thyroid cancer patients using dual-energy CT parameters. Ha T; Kim W; Cha J; Lee YH; Seo HS; Park SY; Kim NH; Hwang SH; Yong HS; Oh YW; Kang EY; Kim C Eur Radiol; 2022 Mar; 32(3):1902-1911. PubMed ID: 34564746 [TBL] [Abstract][Full Text] [Related]
14. Preliminary differentiation of benign and malignant gastric wall thickening using dual-layer spectral-detector CT. Li H; Zhu Q; Liu L; Zou H; Gu D; Wu C; Li W Acta Radiol; 2024 Aug; 65(8):879-888. PubMed ID: 39051549 [TBL] [Abstract][Full Text] [Related]
15. [Comparative imaging study of mediastinal lymph node from pre-surgery dual energy CT Zhu Q; Ren C; Zhang Y; Li MJ; Wang XH Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):730-737. PubMed ID: 32773811 [TBL] [Abstract][Full Text] [Related]
16. Normalized Dual-Energy Iodine Ratio Best Differentiates Renal Cell Carcinoma Subtypes Among Quantitative Imaging Biomarkers From Perfusion CT and Dual-Energy CT. Manoharan D; Netaji A; Diwan K; Sharma S AJR Am J Roentgenol; 2020 Dec; 215(6):1389-1397. PubMed ID: 33052738 [No Abstract] [Full Text] [Related]
17. Clinical value of dual-energy CT for predicting occult metastasis in central neck lymph nodes of papillary thyroid carcinoma. Zhao W; Shen S; Ke T; Jiang J; Wang Y; Xie X; Hu X; Tang X; Han D; Chen J Eur Radiol; 2024 Jan; 34(1):16-25. PubMed ID: 37526667 [TBL] [Abstract][Full Text] [Related]
18. Four-Point Computed Tomography Scores for Evaluation of Occult Peritoneal Metastasis in Patients with Gastric Cancer: A Region-to-Region Comparison with Staging Laparoscopy. Li ZY; Tang L; Li ZM; Li YL; Fu J; Zhang Y; Li XT; Ying XJ; Ji JF Ann Surg Oncol; 2020 Apr; 27(4):1103-1109. PubMed ID: 31965376 [TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical-computed tomography model with 2D and 3D radiomics models to predict occult peritoneal metastases in advanced gastric cancer. Huang J; Chen Y; Zhang Y; Xie J; Liang Y; Yuan W; Zhou T; Gao R; Wen R; Xia Y; Long L Abdom Radiol (NY); 2022 Jan; 47(1):66-75. PubMed ID: 34636930 [TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of disease severity in connective tissue disease-associated interstitial lung disease by dual-energy computed tomography. Chen L; Zhu M; Lu H; Yang T; Li W; Zhang Y; Xie Q; Li Z; Wan H; Luo F Respir Res; 2022 Mar; 23(1):47. PubMed ID: 35248040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]